Springer eBooks may be purchased by end-customers only and are sold without copy protection (DRM free). Instead, all eBooks include personalized watermarks. This means you can read the Springer eBooks across numerous devices such as Laptops, eReaders, and tablets.
You can pay for Springer eBooks with Visa, Mastercard, American Express or Paypal.
After the purchase you can directly download the eBook file or read it online in our Springer eBook Reader. Furthermore your eBook will be stored in your MySpringer account. So you can always re-download your eBooks.
Concepts, Mechanisms, and New Targets for Chemotherapy describes new interconnections between rationally designed and empirically discovered compounds. One route that has not been travelled previously is that of protein kinase C inhibition. This pathway may be exploited to give potent inhibitors, such as the bryostatins, now in clinical trial. A summary is given of the current status of topoisomerase, focusing on recent clinical advances with camptothecin analogs based on connecting empiricism with concepts of drug selectivity. Modification of existing therapies based on the pursuit of leads arising from mechanistic studies is also being applied clinically on a wide scale. Greater understanding should follow from the studies of reversal of the multidrug resistant phenotype, on the use of hydroxyurea to reverse resistance mediated by extrachromosomal DNA, and on various aspects of the fluoropyrimidine pathways. Successful applications of chemotherapy to the treatment of specific diseases include the growing applications of systemic therapy using various skin malignancies. In prostate cancer, estramustine phosphate will likely play an expanding role. Taxanes are restructuring treatment regimens in breast cancer, and high-dose strategies are described with peripheral blood progenitor autografting in the treatment of ovarian and breast cancers.
Content Level »Research
Keywords »DNA - breast cancer - cancer - carcinoma - chemotherapy - clinical trial - diseases - neoplasm - prostate cancer - systemic therapy - therapy - tumor
Preface. I: Concepts and Mechanisms. 1. Potential for Protein Kinase C Inhibitors in Cancer Therapy; P.A. Philip, A.L. Harris. 2. Recent Clinical Advances with Camptothecin Analogues; W.J. Slichenmyer, R.C. Donehower. 3. The Reversal of Multidrug Resistance; G.A. Fisher, et al. 4. Fluoropyrimidine Catabolism; R.B. Diasio, et al. 5. Use of Hydroxyurea to Alter Drug Resistance of Human Tumor Cells; C. van den Berg, D.V. von Hoff. 6. Aspects of One-Carbon Folate Cycling Related to Fluoropyrimidine and Antifolate Therapy; C.V. Spears, et al. II: Disease Targets. 7. Systemic Therapy of Skin Carcinoma; R.F. Kempf. 8. Estramustine Revisited; W. Kreis. 9. Taxoid Compounds in Breast Cancer: Current Status and Future Prospects; M.J. Piccart. 10. High-Dose Chemotherapy with Peripheral Blood Progenitor Autografting; J.P. Crown, D. Fennelly. Index.